The Renin-Angiotensin-Aldosterone System: Cardiorenal Effects and Implications for Renal and Cardiovascular Disease States

This publication has 98 references indexed in Scilit:

• A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
  New England Journal of Medicine, 2001
• Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study)
  The American Journal of Cardiology, 2000
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
  New England Journal of Medicine, 1999
• Angiotensin II Activates the Proinflammatory Transcription Factor Nuclear Factor-κB in Human Monocytes
  Biochemical and Biophysical Research Communications, 1999
• Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
  Published by Elsevier ,1997
• Angiotensin II Type 2 Receptor Inhibits Cell Proliferation and Activates Tyrosine Phosphatase
  Hypertension, 1996
• Blockade of the Renin-Angiotensin System in Cardiac Pressure-Overload Hypertrophy in Rats
  Hypertension, 1995
• Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture.
  Hypertension, 1990
• Hyperinsulinemia and the aldosterone and pressor responses to angiotensin II.
  Hypertension, 1990
• Dietary Protein Intake and the Progressive Nature of Kidney Disease:
  New England Journal of Medicine, 1982